iShares US Pharmaceuticals ETF
IHE
IHE
194 hedge funds and large institutions have $658M invested in iShares US Pharmaceuticals ETF in 2026 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 63 increasing their positions, 37 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 178 → 194 (+16)
1.2% more ownership
Funds ownership: 64.92% → 66.11% (+1.2%)
Holders
194
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$25.1M | |
| 2 | +$17.7M | |
| 3 | +$14.3M | |
| 4 |
IWS
Insight Wealth Strategies
San Ramon,
California
|
+$10.4M |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$8.35M |
Top Sellers
| 1 | -$6.37M | |
| 2 | -$5.1M | |
| 3 | -$4.35M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.56M |
| 5 |
BCV
Banque Cantonale Vaudoise
Lausanne,
Switzerland
|
-$2.08M |
